Resumen

SOSA-MURILLO, Homero O. et al. Endovascular revascularization in Buerger's disease. Rev. mex. angiol. [online]. 2020, vol.48, n.3, pp.100-106.  Epub 23-Ago-2021. ISSN 2696-130X.  https://doi.org/10.24875/rma.20000011.

Buerger's disease (thromboangiitis obliterans) is a rare entity, commonly affecting young men (<45 years) and always associated with smoking. This affection can get to compromise the extremity, being cause of major amputations. Today, it continues to be a disease of unknown etiology; however, its pathogenesis is attributed to various mechanisms, especially autoimmune, proinflammatory and hypercoagulable states. It involves the affection of the distal vessels of the extremities, through a non-atherosclerotic process, with inflammatory and thrombotic pathophysiology, always associated with smoking as the main etiopathogenic factor. Endovascular therapy with percutaneous transluminal angioplasty has recently boomed as a valid therapeutic option in patients with Buerger. In some series, favorable results are evident, with a 12-month success rate of up to 86.7% in limb salvage rate (LSR) and 66.7% in improvement of symptoms with a low rate of complications, so today it is a safe and effective procedure for the preservation of the extremities.

Palabras llave : Obliterating thromboangeitis; Buerger´s disease; Endovascular therapy; Stent placement.

        · resumen en Español     · texto en Español     · Español ( pdf )